Screening developability and pre-formulation of biotherapeutics with high-throughput dynamic light scattering

As the pharmaceutical industry targets increasingly complex biologic candidates, automated formulation and analytical workflows play an important role in streamlining the development process. Explore the technology that powers automated high-throughput dynamic light scattering (HT–DLS) and its practical applications in candidate and formulation selection. Capable of performing 96 runs in under 45 minutes and 384 wells in 1.5–2 hours, with completely unattended operation, discover how high-performance HT–DLS accelerates analysis time, reduces the need for expert operator supervision, and improves confidence in data quality.